ILLUMINA INC (ILU.DE) Stock Fundamental Analysis

FRA:ILU • US4523271090

97.71 EUR
+1.92 (+2%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ILU. ILU was compared to 18 industry peers in the Life Sciences Tools & Services industry. ILU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ILU has a decent growth rate and is not valued too expensively. This makes ILU very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ILU had positive earnings in the past year.
  • ILU had a positive operating cash flow in the past year.
  • In multiple years ILU reported negative net income over the last 5 years.
  • ILU had a positive operating cash flow in 4 of the past 5 years.
ILU.DE Yearly Net Income VS EBIT VS OCF VS FCFILU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.38%, ILU belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
  • The Return On Equity of ILU (29.53%) is better than 100.00% of its industry peers.
  • The Return On Invested Capital of ILU (16.25%) is better than 94.44% of its industry peers.
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROIC 16.25%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILU.DE Yearly ROA, ROE, ROICILU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • ILU has a Profit Margin of 16.39%. This is amongst the best in the industry. ILU outperforms 83.33% of its industry peers.
  • In the last couple of years the Profit Margin of ILU has remained more or less at the same level.
  • Looking at the Operating Margin, with a value of 20.41%, ILU belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • ILU's Operating Margin has improved in the last couple of years.
  • ILU's Gross Margin of 66.74% is amongst the best of the industry. ILU outperforms 94.44% of its industry peers.
  • ILU's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
OM growth 3Y38.39%
OM growth 5Y2.71%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILU.DE Yearly Profit, Operating, Gross MarginsILU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILU is creating some value.
  • ILU has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ILU has been increased compared to 5 years ago.
  • The debt/assets ratio for ILU has been reduced compared to a year ago.
ILU.DE Yearly Shares OutstandingILU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILU.DE Yearly Total Debt VS Total AssetsILU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 3.96 indicates that ILU is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ILU (3.96) is better than 72.22% of its industry peers.
  • The Debt to FCF ratio of ILU is 1.99, which is an excellent value as it means it would take ILU, only 1.99 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.99, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • ILU has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ILU (0.42) is better than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Altman-Z 3.96
ROIC/WACC1.53
WACC10.64%
ILU.DE Yearly LT Debt VS Equity VS FCFILU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.43 indicates that ILU should not have too much problems paying its short term obligations.
  • The Current ratio of ILU (1.43) is better than 61.11% of its industry peers.
  • ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.12, ILU is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
ILU.DE Yearly Current Assets VS Current LiabilitesILU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.96%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 1.51% on average over the past years.
  • The Revenue has decreased by -0.66% in the past year.
  • ILU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.04% yearly.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • Based on estimates for the next years, ILU will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.14% on average per year.
  • Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 6.07% on average per year.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y6.07%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ILU.DE Yearly Revenue VS EstimatesILU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILU.DE Yearly EPS VS EstimatesILU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.89 indicates a rather expensive valuation of ILU.
  • ILU's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.68. ILU is around the same levels.
  • Based on the Price/Forward Earnings ratio of 22.39, the valuation of ILU can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU is on the same level as its industry peers.
  • ILU is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.89
Fwd PE 22.39
ILU.DE Price Earnings VS Forward Price EarningsILU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ILU is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.71
EV/EBITDA 15.82
ILU.DE Per share dataILU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILU does not grow enough to justify the current Price/Earnings ratio.
  • ILU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.54
PEG (5Y)15.83
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ILU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

FRA:ILU (2/13/2026, 7:00:00 PM)

97.71

+1.92 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap14.93B
Revenue(TTM)4.34B
Net Income(TTM)703.00M
Analysts72.31
Price Target114.99 (17.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)7.13%
PT rev (3m)17.83%
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)0.6%
EPS NY rev (1m)1.01%
EPS NY rev (3m)2.37%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 23.89
Fwd PE 22.39
P/S 4.13
P/FCF 17.71
P/OCF 15.78
P/B 7.44
P/tB 16.98
EV/EBITDA 15.82
EPS(TTM)4.09
EY4.19%
EPS(NY)4.36
Fwd EY4.47%
FCF(TTM)5.52
FCFY5.65%
OCF(TTM)6.19
OCFY6.34%
SpS23.66
BVpS13.14
TBVpS5.75
PEG (NY)3.54
PEG (5Y)15.83
Graham Number34.77
Profitability
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROCE 20.76%
ROIC 16.25%
ROICexc 23.32%
ROICexgc 42.83%
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
FCFM 23.32%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y3.11%
ROICexgc growth 5Y5.93%
ROICexc growth 3Y76.04%
ROICexc growth 5Y5.12%
OM growth 3Y38.39%
OM growth 5Y2.71%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Debt/EBITDA 0.86
Cap/Depr 44.36%
Cap/Sales 2.85%
Interest Coverage 250
Cash Conversion 97.57%
Profit Quality 142.25%
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 3.96
F-Score7
WACC10.64%
ROIC/WACC1.53
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y6.07%
EBIT growth 1Y154.36%
EBIT growth 3Y35.92%
EBIT growth 5Y8.92%
EBIT Next Year30.31%
EBIT Next 3Y19.36%
EBIT Next 5Y16.64%
FCF growth 1Y82.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.98%
OCF growth 3YN/A
OCF growth 5YN/A

ILLUMINA INC / ILU.DE FAQ

What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.


What is the valuation status for ILU stock?

ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILU.DE) stock?

ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.


Can you provide the financial health for ILU stock?

The financial health rating of ILLUMINA INC (ILU.DE) is 7 / 10.